Ari Morgenthau

Dr. Ari Morgenthau is an endocrinologist at the University Health Network in Toronto, where he oversees the familial hypercholesterolemia (FH) component of the OurGenes study. His research is centered on recognizing and managing genetic conditions that predispose individuals to health risks, particularly those related to cholesterol, with the aim of improving early detection and treatment strategies in patients.